Akebia Therapeutics, Inc.AKBANASDAQ
Loading
Year-over-year total asset growth rate
Percentile
P74
Within normal range
vs 2Y Ago
1.2x
Modest growth
Streak
3 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 3.41% |
| Q3 2025 | 5.37% |
| Q2 2025 | 11.42% |
| Q1 2025 | 40.57% |
| Q4 2024 | 6.53% |
| Q3 2024 | -5.93% |
| Q2 2024 | -2.34% |
| Q1 2024 | -6.71% |
| Q4 2023 | 2.85% |
| Q3 2023 | -7.38% |
| Q2 2023 | -8.36% |
| Q1 2023 | -22.24% |
| Q4 2022 | -18.32% |
| Q3 2022 | -16.46% |
| Q2 2022 | -2.53% |
| Q1 2022 | 1.14% |
| Q4 2021 | -12.11% |
| Q3 2021 | -1.57% |
| Q2 2021 | -2.68% |
| Q1 2021 | -2.40% |
| Q4 2020 | -4.73% |
| Q3 2020 | -9.26% |
| Q2 2020 | -5.40% |
| Q1 2020 | 2.14% |
| Q4 2019 | -3.02% |
| Q3 2019 | -3.44% |
| Q2 2019 | -7.55% |
| Q1 2019 | -10.61% |
| Q4 2018 | 146.77% |
| Q3 2018 | -2.41% |
| Q2 2018 | -6.54% |
| Q1 2018 | 21.54% |
| Q4 2017 | 7.58% |
| Q3 2017 | 0.52% |
| Q2 2017 | 29.92% |
| Q1 2017 | -13.64% |
| Q4 2016 | 77.52% |
| Q3 2016 | -13.55% |
| Q2 2016 | -11.65% |
| Q1 2016 | 54.92% |